Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03669965
Title KRT-232 Compared to Ruxolitinib in Patients With Phlebotomy-Dependent Polycythemia Vera
Recruitment Unknown status
Gender both
Phase Phase II
Variant Requirements No
Sponsors Kartos Therapeutics, Inc.
Indications

polycythemia vera

Therapies

Ruxolitinib

KRT-232

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU


No variant requirements are available.